Cross-Sector entity
Of the tracked stories, 4 of 4 also mention Aeva Technologies, the most common co-covered peer. The clearest coverage concentration is earnings: 3 of 4 stories, with the rest divided among 1 other category. Each carries 11 original sources on average.
4 verified stories tracked
Last mentioned: Feb 27, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 4 of 4 also mention Aeva Technologies, the most common co-covered peer. The clearest coverage concentration is earnings: 3 of 4 stories, with the rest divided among 1 other category. Each carries 11 original sources on average. We currently track 4 Cross-Sector stories that mention Arlo Technologies, all published on February 27, 2026.
Computed from the 4 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Arlo Technologies. Shared-story counts are live from our verified record — not editorial picks.
EU Regulatory Milestone
Crinetics receives positive CHMP opinion for Palsonify in the European Union.
EU Expansion
Positive CHMP opinion received, enabling commercialization in the European Union.
Crinetics Capital Raise
Public offering brings Crinetics' total liquidity to approximately $1.4B.
Public Offering
Crinetics raises capital, bringing total cash position to $1.4 billion.
NVIDIA Reference Status
Aeva 4D LiDAR selected as reference sensor for NVIDIA DRIVE Hyperion.
Q4 Milestone
Over 200 enrollment forms and 125 unique prescribers recorded for Palsonify.
Palsonify Launch
Crinetics initiates U.S. commercial launch of Palsonify for acromegaly.
Q4 2025 earnings reports highlight a strategic shift toward AI-integrated hardware and high-margin services, with Aeva securing a pivotal NVIDIA partnership and Arlo achieving record SaaS metrics. Meanwhile, Crinetics successfully launched Palsonify, backed by a massive $1.4 billion cash reserve to fuel global expansion.
The Q4 2025 earnings cycle highlights a significant shift toward recurring revenue and high-performance computing (HPC) across the hardware and biotech sectors. Arlo Technologies achieved a landmark Rule of 40 score, while TeraWulf and Aeva Technologies signaled deeper integrations into the AI infrastructure ecosystem.
A wave of Q4 2025 earnings reports highlights a pivotal shift for growth-stage technology and biotech firms as they transition from R&D to commercial scaling. Crinetics and Aeva Technologies emerged as standout performers, securing massive cash reserves and tier-one partnerships that validate their long-term market positions.
The Q4 2025 earnings season highlights a divergence between high-growth DTC brands like FIGS and Arlo, which are successfully leveraging recurring services, and industrial tech firms like PureCycle and Aeva transitioning into full-scale production. While margin pressures from tariffs persist, robust cash positions and strategic partnerships with giants like NVIDIA are fortifying market leaders.
